Treatment of primary Sjögren's syndrome with hydroxychloroquine: A retrospective, open-label study

Lupus

Volumn 5, Issue SUPPL. 1, 1996, Pages

  Fox, R I ^a   Dixon, R ^a   Guarrasi, V ^a   Krubel, S ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Antimalarial; Hydroxycloroquine; Sj gren's syndrome

Indexed keywords

ANTIMALARIAL AGENT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; ROSE BENGAL; ANTIRHEUMATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CORNEA; DISEASE ACTIVITY; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LABORATORY TEST; MALE; PAIN; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SALIVATION; SCHOOL CHILD; SJOEGREN SYNDROME; TEAR FLOW; CHILD; CLINICAL TRIAL; KERATOCONJUNCTIVITIS SICCA; MIDDLE AGED; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; ANTIRHEUMATIC AGENTS; CHILD; FEMALE; HUMANS; HYDROXYCHLOROQUINE; KERATOCONJUNCTIVITIS SICCA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SJOGREN'S SYNDROME; XEROSTOMIA;

EID: 0029991840     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203396005001081     Document Type: Article

References (22)

1. Ruzicka T et al. Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine. Br J Dermatol 1992; 127: 513-518.
2. Dubois E. Antimalarials in the management of systemic lupus erythematosus. Semin Arthritis Rheum 1978; 8: 35.
3. Rudnicki R, Gresham G, Rothfield N. The efficacy of antimalarials in systemic lupus erythematosus. J Rheumatol 1975; 7: 223.
4. Ziff M, Esserman P, McKwan C. Observatons on the course and treatment of systemic lupus erythematosus. Arthritis Rheum 1958; 1: 332.
5. Fox RI et al. Treatment of primary Sjögren's syndrome with hydroxychloroquine. Am J Med 1988; 85: 62-67.
6. Kruize A et al. Hydroxychloroquine treatment for primary Sjögren's syndrome: A two-year double-blind crossover trial. Ann Rheum Dis 1993; 52: 360.
7. Lemp, M. Report of National Eye Institute/Industry Workshop on Clinical Trials for Dry Eyes. Arch Ophthalmol 1996 (in press).
8. Vitali C et al. Preliminary Criteria for the classification of Sjögren's syndrome - Results of a prospective concerted action support by the European community. Arthritis Rheum 1993; 36(3): 340-347.
9. Fox R, Saito I. Criteria for diagnosis of Sjögren's syndrome. Rheum Dis Clin North Am: Current Controversies in Rheumatology 1993; 20: 391.
10. Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome. Arthritis Rheum 1984; 27: 147-156.
11. Fox RI. Epidemiology, pathogenesis and treatment of Sjögren's syndrome. Current Opinion Rheum 1994; 6: 501-508.
12. Atkinson J et al. Major salivary gland function in primary Sjögren's syndrome and its relationship to clinical features. J Rheumatol 1990; 17: 318-325.
13. Daniels TE, Whitcher JP. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum 1994; 37: 869-877.
14. Fox RI, Chan EK, Kang H. Laboratory evaluation of patients with Sjögren's syndrome. Clin Biochem 1992; 25: 213-222.
15. Fox RI, Howell FV, Bone RC, Michelson P. Primary Sjögren's syndrome: Clinical and immunopathologic features. Semin Arthritis Rheum 1984; 14: 77.
16. Tan E et al. Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder. Arch Neurol 1994; 51: 194-200.
17. Fox RI, Kang HI. Mechanism of action of hydroxychloroquine as an antirheumatic drug. Semin Arthritis Rheum 1993; 23: 82-91.
18. Pincus T. Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials. J Clin Epidemiol 1988; 41: 1037-1041.
19. The Canadian Hydroxychloroquine Study Group: A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med. 1991; 324: 150-154.
20. Bernstein HN. Ocular safety of hydroxychloroquine. Ann Ophthalmol 1991; 23: 292-296.
21. Fox RI. Sjögren's syndrome. Current Opinion Rheum 1995; 7: 409-414.
22. Van Gestel A et al. Development and validation of European league against rheumatism responsive criteria for rheumatoid arthritis. Arth Rheum 1996; 39: 34-40.